191 related articles for article (PubMed ID: 3932137)
21. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
22. Gastric acid secretion and duodenal ulcer healing during treatment with omeprazole. A Scandinavian Multicentre Study.
Scand J Gastroenterol; 1984 Oct; 19(7):882-4. PubMed ID: 6397846
[TBL] [Abstract][Full Text] [Related]
23. Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs.
De Graef J; Woussen-Colle MC
Gastroenterology; 1986 Aug; 91(2):333-7. PubMed ID: 2873074
[TBL] [Abstract][Full Text] [Related]
24. Effect of daily oral omeprazole on 24 hour intragastric acidity.
Walt RP; Gomes MD; Wood EC; Logan LH; Pounder RE
Br Med J (Clin Res Ed); 1983 Jul; 287(6384):12-4. PubMed ID: 6407676
[TBL] [Abstract][Full Text] [Related]
25. Effects of omeprazole in duodenal ulcer patients.
Karvonen AL; Keyriläinen O; Uusitalo A; Salaspuro M; Tarpila S; Andrén K; Helander HF
Scand J Gastroenterol; 1986 May; 21(4):449-54. PubMed ID: 3523740
[TBL] [Abstract][Full Text] [Related]
26. Intravenous omeprazole rapidly raises intragastric pH.
Walt RP; Reynolds JR; Langman MJ; Smart HL; Kitchingman G; Somerville KW; Hawkey CJ
Gut; 1985 Sep; 26(9):902-6. PubMed ID: 4029717
[TBL] [Abstract][Full Text] [Related]
27. Acid inhibitory characteristics of omeprazole in man.
Cederberg C; Ekenved G; Lind T; Olbe L
Scand J Gastroenterol Suppl; 1985; 108():105-12. PubMed ID: 3858972
[TBL] [Abstract][Full Text] [Related]
28. Omeprazole, a long-lasting inhibitor of gastric secretion.
Larson GM; Sullivan HW
J Surg Res; 1984 May; 36(5):503-7. PubMed ID: 6727328
[TBL] [Abstract][Full Text] [Related]
29. Twenty-four hour intragastric acidity during treatment with oral omeprazole.
Pounder RE; Sharma BK; Walt RP
Scand J Gastroenterol Suppl; 1986; 118():108-17. PubMed ID: 3460165
[TBL] [Abstract][Full Text] [Related]
30. Gastric secretory and plasma hormonal responses to sham-feeding of varying duration in patients with duodenal ulcer.
Konturek SJ; Swierczek J; Kwiecień N; Obtutowicz W; Dobrzańska M; Kopp B; Oleksy J
Gut; 1981 Dec; 22(12):1003-10. PubMed ID: 6797873
[TBL] [Abstract][Full Text] [Related]
31. Marked increase in gastric acid secretory capacity after omeprazole treatment.
Waldum HL; Arnestad JS; Brenna E; Eide I; Syversen U; Sandvik AK
Gut; 1996 Nov; 39(5):649-53. PubMed ID: 9026477
[TBL] [Abstract][Full Text] [Related]
32. Omeprazole inhibition of nocturnal gastric secretion in patients with duodenal ulcer.
Hetzel DJ; Shearman DJ
Br J Clin Pharmacol; 1984 Oct; 18(4):587-90. PubMed ID: 6487498
[TBL] [Abstract][Full Text] [Related]
33. Acid secretory responses and parietal cell sensitivity following duodenal ulcer healing with omeprazole, sucralfate, and Maalox.
Johnston DA; Marks IN; Young GO; Tigler-Wybrandi NA; Bridger S; Zak J
Am J Med; 1991 Aug; 91(2A):91S-94S. PubMed ID: 1882910
[TBL] [Abstract][Full Text] [Related]
34. Aspects of the effect of metiamide on pentagastrin-stimulated and basal gastric secretion of acid and pepsin in man.
Thjodleifsson B; Wormsley KG
Gut; 1975 Jul; 16(7):501-8. PubMed ID: 1098968
[TBL] [Abstract][Full Text] [Related]
35. Reduction of pentagastrin stimulated acid output: a suitable method to predict efficacy of an irreversible proton pump inhibitor in peptic ulcer disease?
Bliesath H; Simon B; Hartmann M; Müller P; Schneider A; Lühmann R; Wurst W
Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):439. PubMed ID: 1337063
[No Abstract] [Full Text] [Related]
36. Histamine and duodenal ulcer: effect of omeprazole on gastric histamine in patients with duodenal ulcer.
Man WK; Thompson JN; Baron JH; Spencer J
Gut; 1986 Apr; 27(4):418-22. PubMed ID: 2420686
[TBL] [Abstract][Full Text] [Related]
37. Interaction of glucagon and pentagastrin on pepsin secretion in healthy subjects.
Christiansen J; Holst JJ; Molin J
Gut; 1982 Jun; 23(6):528-31. PubMed ID: 6804315
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
Pratha VS; Hogan DL; Lane JR; Williams PJ; Burton MS; Lynn RB; Karlstadt RG
Dig Dis Sci; 2006 Jan; 51(1):123-31. PubMed ID: 16416224
[TBL] [Abstract][Full Text] [Related]
39. Antisecretory activity of pirenzepine versus cimetidine in man: a controlled study.
Procacciante F; Citone G; Montesani C; Ribotta G
Gut; 1984 Feb; 25(2):178-82. PubMed ID: 6546371
[TBL] [Abstract][Full Text] [Related]
40. Decrease in gastric secretion during the first three months after proximal gastric vagotomy in duodenal ulcer patients.
Roland M; Berstad A; Liavåg I
Scand J Gastroenterol; 1975; 10(4):363-7. PubMed ID: 1098130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]